Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
CollPlant initial breast implant data ‘encouraging,’ says H.C. Wainwright
H.C. Wainwright maintains a Buy rating and 12-month price target of $11 on CollPlant (CLGN) shares after the company reported Q3 results and ...
bovnews1d
H.C. Wainwright Issues Buy Rating for Quantum-Si Inc (QSI) Stock
H.C. Wainwright has recently initiated Quantum-Si Inc (QSI) stock to Buy rating, as announced on December 8, 2023, according to Finviz. Earlier, on September 25, 2023, Canaccord Genuity had reduced ...
Alector price target lowered to $7 from $35 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating ...
Iris Energy price target raised to $16 from $13 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Iris Energy (IREN) to $16 from $13 and keeps a Buy rating on the shares. The company is ...
bovnews3d
H.C. Wainwright Just Downgraded Eyenovia Inc (EYEN) Stock—What Does This Mean for Investors?
H.C. Wainwright has recently reduced Eyenovia Inc (EYEN) stock to Neutral rating, as announced on November 18, 2024, according to Finviz. Earlier, on March 1, 2021, Northland Capital had initiated the ...
Nasdaq4d
Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Arthur He downgraded Poseida Therapeutics (PSTX) to Neutral from Buy with a price target of $9, down from $20, after Roche (RHHBY) agreed to acquire the company for $1.5B ...
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...
Nasdaq5d
BridgeBio price target raised to $49 from $43 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on BridgeBio (BBIO) to $49 from $43 and keeps a Buy rating on the shares. Acoramidis received regulatory approval with the label underscoring ...
Seeking Alpha18d
Phunware stock slides after downgrade to Neutral at H.C. Wainwright
Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck ...
Financial Post5d
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
today announced that the Company will participate in the virtual H.C Wainwright @ Home fireside chat series taking place on Tuesday, December 3, 2024 at 11:00 am ET. We apologize, but this video has ...
Investing4d
H.C. Wainwright maintains Neutral rating on Mawson stock amid evolving strategy
On Tuesday, H.C. Wainwright maintained a Neutral rating for Mawson Infrastructure Group Inc. (NASDAQ: MIGI), following the company's recent production report. Mawson Infrastructure, transitioning from ...